Mode
Text Size
Log in / Sign up

Glucocorticoid signaling and stress-related neuroendocrine dysregulation influence intraocular pressure and inflammatory pathways in ocular diseasesStress and hormones may play a role in eye health

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Recognize stress-related neuroendocrine dysregulation as a factor influencing intraocular pressure and inflammation.

This narrative literature overview synthesizes 35 studies regarding glucocorticoid signaling and stress-related neuroendocrine dysregulation in various ocular conditions, including glaucoma, ocular surface disease, and central serous chorioretinopathy (CSC). The authors argue that HPA axis and sympathetic nervous system activation influence critical biological processes such as intraocular pressure regulation, inflammatory signaling, vascular permeability, and neurodegenerative pathways.

Glucocorticoids are identified as indispensable for the management of inflammatory and immune-mediated ocular diseases. However, the review notes that glucocorticoid use is associated with risks including ocular hypertension, glaucoma, cataract formation, delayed wound healing, and increased susceptibility to infection. The synthesis suggests that these factors contribute significantly to the pathophysiology of the mentioned conditions.

Clinical implications suggest that recognizing stress as a modifiable contributor to ocular health may facilitate more individualized and multidisciplinary approaches to ophthalmic care. While the review highlights emerging concepts like chronobiology and advanced delivery systems, it does not provide specific data on their efficacy. The association between neuroendocrine dysregulation and ocular disorders is noted rather than proven as causal.

How this fits prior evidence

This narrative review addresses a gap in understanding the underlying mechanisms of glaucoma, ocular surface disease, and central serous chorioretinopathy (CSC). It expands upon previous coverage regarding CSC by focusing on internal biological pathways rather than systemic markers like C-reactive protein. While it confirms the role of glucocorticoids in managing inflammatory conditions, it highlights specific risks such as glaucoma and cataract formation that were not detailed in prior reports.

Living with an eye condition can be stressful, but your body might also be reacting to stress in ways that affect your vision. A review of 35 studies looked at how the body's stress response system—specifically hormones like glucocorticoids—impacts eye health. These chemicals are essential for managing inflammation and immune responses.

The research found that when the body's stress systems get out of balance, it can influence several key processes. This includes how your eyes regulate pressure, how they handle inflammation, and how blood vessels behave. These factors are all linked to conditions like glaucoma, ocular surface disease, and central serous chorioretinopathy.

While glucocorticoids are necessary tools for treating certain eye diseases, they can cause side effects like high eye pressure or cataracts if not managed correctly. This work suggests that looking at how stress affects the body could help doctors create more personalized care plans for patients with chronic eye conditions.

What this means for you:
Stress-related hormone changes may influence eye pressure and inflammation in several common eye conditions.

Common questions

What role do hormones play in eye conditions?

Glucocorticoids are a type of hormone that your body uses to manage inflammation and immune responses. They are essential for treating certain eye diseases, but they can also cause side effects like high eye pressure or cataracts if not managed properly.

How does stress affect the eyes?

When the body's stress response system becomes unbalanced, it can impact several biological processes. This includes how your eyes regulate internal pressure, manage inflammation, and handle blood vessel permeability, all of which are important for maintaining healthy vision.

What eye conditions are linked to these hormone changes?

The review found that stress-related hormonal issues are associated with glaucoma, ocular surface disease, and central serous chorioretinopathy. These findings suggest that looking at how the body handles stress could help doctors provide more individualized care.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedJul 2026
View Original Abstract ↓
This narrative overview examines the interplay between stress-related neuroendocrine dysregulation, glucocorticoid signaling, and ocular health, with particular emphasis on their roles in ocular disease pathophysiology and clinical management. A structured literature search was conducted using PubMed, Scopus, and Web of Science to identify English-language peer-reviewed studies published between January 2013 and May 2025. Additional records were identified through manual screening of reference lists. Following title, abstract, and full-text evaluation according to predefined eligibility criteria, 35 studies were included in the final narrative synthesis. The available evidence indicates that activation of the hypothalamic–pituitary–adrenal axis and sympathetic nervous system influence key biological processes involved in ocular homeostasis, including intraocular pressure regulation, inflammatory signaling, vascular permeability, and neurodegenerative pathways. Stress-related neuroendocrine dysregulation has been associated with several ocular disorders, particularly glaucoma, ocular surface disease, and central serous chorioretinopathy (CSC). At the same time, glucocorticoids remain indispensable therapeutic agents for the management of inflammatory and immune-mediated ocular diseases, although their use may be accompanied by adverse effects such as ocular hypertension, glaucoma, cataract formation, delayed wound healing, and increased susceptibility to infection. The review further highlights emerging concepts related to chronobiology, advanced corticosteroid delivery systems, and personalized treatment approaches aimed at optimizing therapeutic efficacy while minimizing treatment-related complications. Collectively, the findings support an integrated model in which neuroendocrine, inflammatory, vascular, and psychosocial factors interact to influence ocular disease susceptibility, progression, and treatment outcomes. Greater recognition of stress as a modifiable contributor to ocular health may facilitate the development of more individualized and multidisciplinary approaches to ophthalmic care.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.